Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6991 AL 7005

The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease

Gülcan HO, Orhan IE.

Curr Pharm Des. 2020;26(4):509-516. doi: 10.2174/1381612826666200131103524.

Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's

Nirale P, Paul A, Yadav KS.

Life Sci. 2020 Mar 15;245:117394. doi: 10.1016/j.lfs.2020.117394. Epub 2020 Feb 1.

A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease

Ettcheto M, Busquets O, Espinosa-Jiménez T, Verdaguer E, Auladell C, Camins A.

Curr Pharm Des. 2020;26(12):1286-1299. doi: 10.2174/1381612826666200211121416.

Healthy Effects of Plant Polyphenols: Molecular Mechanisms

Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, Stefani M.

Int J Mol Sci. 2020 Feb 13;21(4):1250. doi: 10.3390/ijms21041250.

Brain insulin resistance: role in neurodegenerative disease and potential for targeting

Hölscher C.

Expert Opin Investig Drugs. 2020 Apr;29(4):333-348. doi: 10.1080/13543784.2020.1738383. Epub 2020 Mar 16.

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors

Ren SY, Wang ZZ, Zhang Y, Chen NH.

Acta Pharmacol Sin. 2020 Oct;41(10):1263-1271. doi: 10.1038/s41401-020-0385-7. Epub 2020 Mar 18.

5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease

Chen F, Ghosh A, Lin J, Zhang C, Pan Y, Thakur A, Singh K, Hong H, Tang S.

Brain Behav Immun. 2020 Aug;88:844-855. doi: 10.1016/j.bbi.2020.03.022. Epub 2020 Mar 25.

Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis

Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song BJ, Zhou S, Wang X.

Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316.

Lipids Nutrients in Parkinson and Alzheimer's Diseases: Cell Death and Cytoprotection

Nury T, Lizard G, Vejux A.

Int J Mol Sci. 2020 Apr 3;21(7):2501. doi: 10.3390/ijms21072501.

Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches

Bhattamisra SK, Shin LY, Saad HIBM, Rao V, Candasamy M, Pandey M, Choudhury H.

CNS Neurol Disord Drug Targets. 2020;19(3):174-183. doi: 10.2174/1871527319666200518102130.

Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases

Krahn AI, Wells C, Drewry DH, Beitel LK, Durcan TM, Axtman AD.

ACS Chem Neurosci. 2020 Jul 1;11(13):1871-1886. doi: 10.1021/acschemneuro.0c00176. Epub 2020 Jun 11.

Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

Miller JH, Das V.

Curr Pharm Des. 2020;26(35):4362-4372. doi: 10.2174/1381612826666200621171302.

Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Fantini J, Chahinian H, Yahi N.

Protein Sci. 2020 Aug;29(8):1748-1759. doi: 10.1002/pro.3906. Epub 2020 Jul 13.

Epigenetic Basis of Lead-Induced Neurological Disorders

Wang T, Zhang J, Xu Y.

Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.

Glibenclamide as a neuroprotective antidementia drug

Zubov A, Muruzheva Z, Tikhomirova M, Karpenko M.

Arch Physiol Biochem. 2022 Dec;128(6):1693-1696. doi: 10.1080/13813455.2020.1789170. Epub 2020 Jul 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias